Estrogen signaling fulfills a crucial role in the regulation of growth and survival of estrogen-dependent tumors that account for the majority of cases of BC, signifying that endocrine therapy is a promising measure aimed at the treatment of ER+ BC cells [12]. Here, ESR1 is linked to breast cancer.